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Abstract
Introduction: The bispectral index (BIS) is an attractive approach for monitoring level
of consciousness in critically ill patients, particularly during paralysis, when commonly
used sedation scales cannot be used.
Objectives: As a first step toward establishing the utility of BIS during paralysis, this
review examines the strength of correlation between BIS and clinical sedation scales
in a broad population of non-paralyzed, critically ill adults.
Methods: We included studies evaluating the strength of correlation between concurrent assessments of BIS and Richmond Agitation Sedation Scale (RASS), Ramsay
Sedation Scale (RSS), or Sedation Agitation Scale (SAS) in critically ill adult patients.
Studies involving assessment of depth sedation periperative or procedural time periods, and those reporting BIS and sedation scale assessments conducted >5 min apart
or while neuromuscular blocking agents (NMBA) were administered, were excluded.
Data were abstracted on sedation scale, correlation coefficients, setting, patient characteristics, and BIS assessment characteristics that could impact the quality of the
studies.
Results: Twenty-four studies which enrolled 1235 patients met inclusion criteria. The
correlation between BIS and RASS, RSS, and SAS overall was 0.68 (95% confidence
interval, 0.61–0.74, Ƭ2 = 0.06 I2 = 71.26%). Subgroup analysis by sedation scale indicated that the correlation between BIS and RASS, RSS, and SAS were 0.66 (95%
confidence interval 0.58–0.73, Ƭ2 = 0.01 I2 = 30.20%), 0.76 (95% confidence inter-

val 0.69–0.82, Ƭ2 = 0.04 I2 = 67.15%), and 0.53 (95% confidence interval 0.42–0.63,
Ƭ2 = 0.01 I2 = 26.59%), respectively. Factors associated with significant heterogeneity

included comparator clinical sedation scale, neurologic injury, and the type of intensive care unit (ICU) population.
Conclusions: BIS demonstrated moderate to strong correlation with clinical sedation
scales in adult ICU patients, providing preliminary evidence for the validity of BIS as
a measure of sedation intensity when clinical scales cannot be used. Future studies
should determine whether BIS monitoring is safe and effective in improving outcomes
in patients receiving NMBA treatment.
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(Registration Number: CRD42020158314). This study did not require ethical approval.

Electroencephalographic monitoring with the bispectral index (BIS)
is a method for assessing level of consciousness that can be used
to titrate the dosage of sedative agents in a variety of settings. BIS

2.2 | Study eligibility

monitoring was originally developed for the operating room setting,
where it demonstrates a strong correlation with drug-induced loss of

We included studies evaluating the strength of correlation between

consciousness,1 and randomized trials have shown its use to signifi-

concurrent assessments of BIS and RASS, RSS, or SAS in critically ill

cantly reduce the incidence of accidental awareness during anesthe-

adult patients. We excluded studies involving assessment of depth

sia. 2 The role of BIS in the critically ill population has yet to be clearly

of sedation during perioperative or procedural periods; however, pa-

defined, given the lack of data showing a benefit of BIS compared

tients admitted to the ICU for postoperative care were included. BIS

with commonly used clinical sedation scales.3 However, clinical se-

and clinical sedation scale assessments had to be conducted concur-

dation scales cannot be used in patients treated with neuromuscular

rently and not during a period of neuromuscular blockade. The defi-

blocking agents (NMBA), because such scales require assessment of

nition of “concurrent” was met if the methods stated broadly that

a patient's movement in response to stimulus.

assessments were done at the same time. If a specific time between

NMBA are a common adjuvant therapy for mechanically venti-

assessments was mentioned, it must have been ≤5 min. Studies pub-

lated patients in the intensive care unit (ICU). An estimated one in five

lished in abstract form were included if there was no subsequent

patients with acute respiratory distress syndrome (ARDS) are treated

manuscript with the same dataset and only if outcomes of interest

with a NMBA,4 and the prevalence of use has increased substantially

were reported.

since the advent of the coronavirus disease 2019 (COVID-19) pandemic.5,6 One of the most challenging aspects of NMBA treatment
is the management of sedation. The inability to apply clinical sedation scales during NBMA treatment creates a substantial risk of harm

2.3 | Search strategy, sources, and study
identification

from undersedation (i.e., awareness with paralysis) and oversedation
(i.e., sedatives are infused beyond what is needed). Awareness during

We performed computerized searches of PubMed, Embase

paralysis is a potentially devastating complication that can lead to

(Elsevier), Cochrane Library (include Cochrane Database of

post-traumatic stress disorder.7,8 Further, oversedation may be a

Systematic Reviews and Cochrane Central Register of Controlled

mediator of increased mortality in patients treated with NMBA.9,10

Trials), Scopus (Elsevier), and OpenGrey with the assistance of an

Thus, establishing the utility of BIS as a monitoring tool in paralyzed,

experienced medical librarian (E.F.G.). Searches were conducted

critically ill patients is of considerable interest.

on August 18, 2018, and rerun on November 15, 2019, January 15,

An effective approach to establishing the validity of BIS would

2021, and April 14, 2022. Search strategies combined keywords and

be to examine agreement between BIS and validated clinical seda-

subject headings for the concepts of consciousness monitors, seda-

tion scales. However, doing so directly in NMBA-treated patients is

tion scales, and ICUs (Appendix S1). No date or language restrictions

not feasible. Thus, as a first step toward this goal, we conducted a

were applied. Corresponding authors of studies with missing data

systematic review and meta-analysis to provide a definitive evalua-

were contacted one time to obtain data of interest.

tion of the literature supporting the validity of BIS in non-paralyzed,
critically ill patients. Our primary aim was to determine the strength
of correlation between BIS and the following validated clinical

2.4 | Study selection and data abstraction

scales: Richmond Agitation Sedation Scale (RASS), Ramsay Sedation
Scale (RSS), and Sedation Agitation Scale (SAS).11–13

Title and abstract screening for the initial search results was conducted in Excel. Full-text screening for the initial search and all

2

|

M ATE R I A L S A N D M E TH O DS

2.1 | Protocol and registration

screening for search updates were completed in Covidence.14
Covidence was also used for data abstraction and quality assessment.
Article selection was independently conducted by two authors
(D.D.L. and S.Y.A.Y.) and disagreements were reconciled by a third
author (M.S.H.), who reviewed articles independently and deter-

This review and associated protocol were registered with the

mined relevance. If the third author agreed with either of the two

PROSPERO international prospective register of systematic reviews

authors, that determination was followed. If there was ambiguity

|
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identified by M.S.H., all three authors discussed disagreements

method of DerSimonian and Laird.17 Heterogeneity of correlation

for reconciliation. Data of interest were abstracted from full texts

estimates between studies was examined by calculating the Q sta-

by three authors (D.D.L., S.Y.A.Y., and M.S.H.). Two authors inde-

tistics, derived from the chi-square test, and the inconsistency index

pendently collected and documented data of interest for each in-

(I2). We considered an I2 > 50% to indicate important heterogeneity

cluded study. Disagreements in data collected were reconciled by

between studies and a p-value ≤0.10 as indicating statistically sig-

M.S.H., similar to the process defined above for article selection.

nificant heterogeneity.18

Author, publication year, sponsorship source, country of or-

We specified several subgroup analyses a priori to examine po-

igin, ICU setting, corresponding author information, study design,

tential sources of heterogeneity: sedation scale (RASS vs. RSS vs.

number of patients, and number of assessments were collected.

SAS), depth of sedation targeted (deep sedation [RASS < −3, RSS < 4,

To gain an understanding of the study population and quality, we

SAS < 2] vs. higher levels), signal-quality index assessed (yes vs. no),

also collected data on whether neurologically injured patients were

exclusion of patients with prior NMBA use (yes vs. no), ICU popula-

included, goal depth of sedation, if specified, use and timing of

tion type (mixed vs. medical vs. surgical), inclusion of patients with

NMBA with respect to sedation assessments, monitoring of signal-

neurological injury (yes vs. no), and whether the correlation analysis

quality index, monitoring of electromyogram input, number of BIS

was the study's primary outcome (yes vs. no). We also performed

scores documented at each assessment, number of clinical sedation

several post hoc subgroup analyses, including electromyographic

scores documented at each assessment, percentage of patients

assessment (yes vs. no), approach to BIS measurement (single mea-

receiving mechanical ventilation, sedative and analgesic agents

sure vs. average of multiple measurements), BIS monitor type (XP

administered, severity of illness, and type of BIS monitor and elec-

vs. non-XP), APACHE II score (0–10, 11–20, >20),19 and risk of bias

trodes used during the study. In addition, data on study quality or

(based on bias and applicability ratings).
For the depth of sedation subgroup analysis, we classified scales

risk of bias, and outcomes of interest were collected for each full
study included.

as follows (from deepest to lightest and excluding the agitated states
for clinical scales): BIS 0–39 (ultra-deep), 40–59 (deep), 60–79 (mod-

2.5 | Assessment of methodologic quality

erate), 80–100 (light); RASS −5 to −4 (deep), −3 (moderate), −2 to 0
(light); RSS 6 to 5 (deep), 4 (moderate), 3 to 2 (light); and SAS 1 to 2
(deep), 3 (moderate), 4 (light). 20

QUADAS-2 was used to evaluate the risk of bias in included stud-

We considered a correlation coefficient between 0.0 and 0.09 to

ies. Four key domains of patient selection, index test, reference

be negligible, 0.10 and 0.39 to be weak, 0.40 and 0.69 to be moder-

standard, and flow and timing were evaluated for each study. Three

ate, 0.70 and 0.89 to be strong, and 0.90 and 1.0 to be a very strong

authors (D.D.L., S.Y.A.Y., and M.S.H.) evaluated studies for quality

correlation. 21 We examined the risk of publication bias by visual

and risk of bias. Two authors independently evaluated and docu-

inspection of funnel plots. All analyses were performed with Stata

mented assessment for quality and risk of bias for each domain of

version 17.1 (College Station, TX).

QUADAS-2. Disagreements were reconciled by M.S.H. using the
previously defined approach.

3

|

R E S U LT S

2.6 | Data analysis

3.1 | Study Identification and Selection

Data analysis was conducted by T.A.M. Pooled analyses were based

The comprehensive electronic search yielded 2973 citations.

on the Pearson correlation coefficient (r). Values from studies re-

Removal of duplicates and screening for inclusion criteria yielded 59

porting other correlation measures (Spearman's Rank correlation,

studies. After elimination of 35 studies for exclusion criteria, 24 stud-

Kendall rank correlation) were converted to r values using published

ies enrolling 1235 patients were included in the final analysis. 22–45

equations.15 The primary analysis pooled results from all studies. If

Figure 1 depicts the Preferred Reporting Items for Systematic

a study examined the correlation between BIS and more than one

Review and Meta-Analyses (PRISMA) flow diagram.

clinical scale, the results for only one scale were included in the primary analysis according to the following hierarchy, based on how
widely the scales have been reportedly used in practice16: RASS is

3.2 | Study characteristics

primary, if RASS is not reported, RSS is primary, if RSS not reported,
SAS is primary. Estimation of 95% confidence intervals and pooled

The 24 studies included in the analyses were published between

estimates were obtained after applying the Fischer Z transforma-

2001 and 2015. Eighteen studies enrolled patients in mixed or gen-

tion to approximate a normal sampling distribution, with transforma-

eral ICUs. All studies were prospectively conducted and included

tion back to the correlation scale for presentation. Pooled estimates

only mechanically ventilated patients except one study that did not

were obtained from a random-effects meta-analysis using the

report this information. Nineteen studies evaluated BIS and clinical

4
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F I G U R E 1 Preferred reporting items
for systematic review and meta-analyses
flow diagram for systematic review phases
for correlation between concurrent
measurements of bispectral index (BIS)
and clinical sedation scale assessments

sedation scale correlation as the primary outcome. Nine studies cor-

3.4 | Assessment of methodologic quality

related BIS with RASS, 11 with RSS, and 9 with SAS.
Table 1 summarizes assessments for risk of bias for each study, in

3.3 | Meta-analysis results

each of domain of the QUADAS-2 tool. Ten studies were found to
have low risk of bias, four studies with 1 domain considered high or
unclear risk of bias, and 10 studies with 2 or more domains consid-

When data from all studies were aggregated, the correlation be-

ered high or unclear risk of bias. Seventeen studies had low risk in

tween BIS and clinical sedation scales was 0.68 (95% confidence

the applicability rating and seven studies with 1 or more domains

interval, 0.61–0.74, I2 = 71.26%), demonstrating substantial hetero-

with high or unclear risk in the applicability rating.

geneity across studies (Figure 2). The correlation with BIS varied
significantly by sedation scale (Figure 3), showing the strongest correlation with the RSS scale. The correlation between BIS and clini-

4

|

DISCUSSION

cal scales varied significantly depending on whether patients with
neurological injury were included; the correlation was significantly

In this systematic review and meta-analysis, we observed a

lower in the three studies including patients with neurological in-

moderate-to-s trong correlation between BIS and validated clinical

jury (Figure 4). When the studies were stratified by depth of seda-

sedation scales in a population of critically ill patients who were

tion, the correlation between BIS and clinical sedation scales was

predominantly receiving light sedation. This finding suggests that

stronger with studies including patients undergoing deep sedation

BIS monitoring potentially provides clinically relevant information

(correlation coefficient 0.76 for deep sedation versus 0.68 for light

on level of consciousness in critically ill patients receiving seda-

to moderate sedation). However, heterogeneity was lower across

tion. Application of this finding is limited, however, by substantial

studies with light to moderate sedation (Figure 5). Significant het-

heterogeneity of the correlation across included studies. We in-

erogeneity was also observed when analysis was stratified by ICU

cluded 24 studies in varied patient populations, using three differ-

type (Appendix S2). No significant heterogeneity was observed in

ent clinical sedation scales, and employing numerous differences

the remaining subgroup analyses (Appendix S2).

in methodology. Methodological inconsistencies, such as type of

|
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F I G U R E 2 Meta-analysis and forest
plot of overall correlation between
bispectral index (BIS) and clinical sedation
scales

BIS monitor or electrodes used, timing of clinical and BIS assess-

subgroup analysis across “targeted depth of sedation” categories did

ments, and monitoring of electromyogram input or signal-quality

not explain significant heterogeneity. This analysis is limited by the

index to ensure the appropriateness of the BIS measurements,

fact that most studies did not report on targeted level of sedation,

could explain some of the heterogeneity observed across stud-

and further, the targeted level might not reflect the achieved level

ies. However, subgroup analyses based on these methodological

of sedation at the time of BIS measurement. Although our analysis

factors did not explain substantial heterogeneity. Factors that

is not designed to show this, we postulate that a lack of correlation

were associated with significant heterogeneity included compara-

between BIS and clinical sedation scales may represent a potential

tor clinical sedation scale, neurologic injury, and the type of ICU

advantage of BIS in the setting of lower levels of consciousness,

population.

which is particularly relevant for patients receiving NMBA. We pro-

Subgroup analysis across clinical scales showed the highest correlation between RSS and BIS (0.76), with lower values between BIS

pose this as an important area for future prospective evaluation, in a
critically ill patient population receiving NMBA.

and SAS or BIS and RASS (0.53 and 0.66, respectively). This finding

We also observed that the correlation between BIS and seda-

may be due in part to “ceiling effects” at higher levels of conscious-

tion scores was significantly lower in brain injury studies. Although

ness. BIS reaches a maximum value in patients who are awake.10

the mechanism of this finding is unknown, it might suggest that the

Similarly, the RSS scale assigns the same score to all levels of con-

relationship between BIS and level of consciousness is altered by

sciousness above “alert and calm.” Thus, both BIS and RSS have a

brain injury. Alternatively, lower correlation may reflect the diffi-

ceiling at higher levels of consciousness (e.g., agitation), whereas

culty of clinical assessment in patients with significant brain injury.

RASS and SAS continue to differentiate increasing levels of agita-

Regardless of the mechanism, our data suggest caution with using

tion. Similarly, “floor effects” would be expected on the other end

BIS in the brain-injured population.

of the spectrum; in patients who are deeply sedated, clinical scales

We undertook this evaluation to determine whether BIS could

reach a minimum value at “unarousable.” In contrast, BIS values can,

be an appropriate sedation assessment tool in critically ill adult

at least theoretically, continue to differentiate lower levels of con-

patients treated with NMBA, when clinical sedation scales are im-

sciousness.10 Although this potential non-linear association between

practical. The current standard in this group is to target deep seda-

BIS and clinical scales is plausible based on mechanistic grounds,

tion prior to the initiation of NMBA.46 However, given the inability

6
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F I G U R E 3 Subgroup meta-analysis
and forest plot of correlation between
bispectral index (BIS) and Richmond
Agitation Sedation Scale (RASS), Ramsay
Sedation Scale (RSS), or Sedation
Agitation Scale (SAS)

to continually assess depth of sedation over time, this strategy cre-

increased in-hospital mortality.10 The inability to assess sedation

ates an important risk of oversedation, which has been associated

depth also creates an important risk of undersedation. Although

with worse outcomes. An evaluation of sedation strategies during

awareness with chemical paralysis has been reported with a rate

neuromuscular blockade in ARDS found that a higher proportion of

of 0.1% in the operating room, this incidence may be as high as

deep sedation mediated the harmful effects of NMBA infusions on

3.4% in the emergency department or ICU.47 Taken together, these

9

mortality and ventilator- and ICU-free days. A subsequent analy-

data suggest that strategies for more accurate sedation titration

sis of sedation strategies in mechanically ventilated patients with

could improve outcomes during paralysis. Based on the moderate

COVID-19 demonstrated that patients with COVID-19 have been

correlation observed between BIS and clinical sedation scales in

more deeply sedated, with higher sedative doses, and for longer

non-paralyzed patients, we hypothesize that BIS monitoring may

durations of time as compared with non-COVID-19 mechanically

provide meaningful information about level of consciousness that

ventilated patients with ARDS. Mediation analysis in this study

could improve sedation titration in patients receiving continuous

also showed a strong relationship between deep sedation and

NMBA.

|
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F I G U R E 4 Subgroup meta-analysis
and forest plot of correlation between
bispectral index (BIS) and clinical sedation
scales stratified by inclusion of patients
with neurologic injury

Although our results provide preliminary evidence for the valid-

caution, and we consider our findings to be hypothesis-generating.

ity of BIS in the broad ICU population, important questions remain

Future studies that directly examine BIS validity during NMBA ad-

that limit routine use of this technology in paralyzed patients. In

ministration are needed. A possible approach to this would be lon-

particular, the optimal target BIS range during NMBA treatment is

gitudinal concurrent assessments of BIS and clinical sedation scales

unknown. A study in fully awake, healthy volunteers found that BIS

during transition periods around NMBA administration. Additionally,

values dropped significantly in some awake subjects after the ini-

studies that directly examine the association between BIS monitor-

tiation of NMBA. This suggests that NMBA may directly lower BIS

ing and clinical outcomes are needed. One study comparing BIS to

measurements, potentially by reducing electromyographic activity.48

clinical sedation found no difference in median daily sedation or

Consequently, target BIS ranges must be developed that account

analgesia exposure in patients receiving NMBA in the ICU; a more

for this direct lowering effect in order to avoid inappropriate down-

robust, prospective evaluation is needed.50 A systematic review and

titration of sedation.49 Alternatively, sedation algorithms that incor-

meta-analysis of BIS monitoring for sedation in critically ill mechan-

porate BIS monitoring might specify minimum sedative infusion rates

ically ventilated adults on clinical outcomes or resource utilization

below which patients are not titrated during chemical paralysis, even

found insufficient evidence on the effects of BIS due to uncertainty

if BIS values are numerically below goal range for deep sedation.

of the findings from low- and very low-quality evidence.51 Lastly,

Our analysis was restricted to studies of non-paralyzed patients.

additional research is needed to determine whether a strategy of

Such a restriction was unavoidable, as application of the clinical

NMBA holidays and clinical sedation assessment for titration of sed-

scales requires assessment of patient movement. Consequently, ex-

atives versus continuous titration using BIS would have better out-

trapolation of these results to paralyzed patients should be done with

comes, given the considerations we have discussed.

8
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F I G U R E 5 Subgroup meta-analysis
and forest plot of correlation between
bispectral index (BIS) and clinical sedation
scales stratified by depth of sedation

TA B L E 1 Risk of bias assessment
Risk of bias

Applicability concerns

Study

Patient
selection

Index tests

Reference
standard

Flow and timing

Patient
selection

Index tests

Reference
standard

Riker, 2001

High

High

Low

Low

Low

Low

Low

Nasraway, 2002

High

Low

Low

Low

Low

Low

Low

Riess, 2002

Low

Low

Low

Low

Low

Low

Low

deWit, 2003

Low

Low

Low

Low

Low

Low

Low

Deogaonkar, 2004

Low

Low

Low

Low

High

Low

Low

Ely, 2004

Low

Low

Low

Low

Low

Low

Low

Doi, 2005

Low

High

Unclear

Low

High

Low

Low

Tonner, 2005

Unclear

High

Low

Low

Low

Low

Low

Consales, 2006

Low

Low

Unclear

Low

Low

Low

Low

Ma, 2006

Low

Unclear

Unclear

Low

Low

Low

Low

Turkmen, 2006

High

Unclear

Unclear

Unclear

Low

High

Low

Gu, 2007

Low

Low

Low

Low

Low

Low

Low

Hernandez-Gancedo, 2007

Low

Low

Low

Low

Low

Low

Low

Lu, 2008

Low

High

Low

Low

Low

High

Low

Arbour, 2009

Unclear

High

Low

Low

Low

Low

Low

Li, 2009

Low

High

Unclear

Low

Low

Low

Low

Karamchandani, 2010

Low

Low

Low

Low

Low

Low

Low

Ogilvie, 2011

Low

High

Low

Low

High

High

Low

Jung, 2012

Low

Low

Low

Low

Low

Low

Low

Kato, 2012

Low

High

High

Low

Low

High

Low

LeBlanc, 2012

Low

Low

Low

Low

Low

Low

Low

Yaman, 2012

Low

High

Low

Unclear

Low

Low

Low

Prottengeier, 2014

Unclear

Low

Low

Unclear

Low

Low

Low

Paliwal, 2015

Low

Low

Low

Low

Low

High

Low
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CO N C LU S I O N S
5.

Our results suggest that BIS has moderate to strong correlations
with clinical sedation scales in adult ICU patients, providing preliminary evidence for the validity of BIS as a measure of sedation
intensity when clinical scales cannot be used. However, mapping

6.

specific BIS values to validated clinical sedation scales is hindered
by heterogeneity across studies, and potential ceiling effects at the
extremes of consciousness. This makes implementation of BIS at the
bedside challenging. Although our findings represent an important
step toward defining a role for BIS monitoring during paralysis, additional research is required to use BIS safely during NMBA treatment.

7.

8.

Prospective studies that directly examine the association between
BIS scores and clinical outcomes are needed to identify optimal BIS
ranges that could be applied in routine practice in patients receiving NMBA. Additionally, future research should evaluate the utility

9.

of BIS for titration of sedatives versus paralytic holidays and intermittent clinical assessment in patients undergoing neuromuscular
blockade.
10.
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